Identification | Back Directory | [Name]
3'-deoxy-3'-fluoro-beta-D-xylo-inosine | [CAS]
171667-46-2 | [Synonyms]
3'-xylo-F-Inosine 3’-deoxy-3’-fluoro-β-D-xylo-inosine 3'-deoxy-3'-fluoro-beta-D-xylo-inosine 6H-Purin-6-one, 9-(3-deoxy-3-fluoro-β-D-xylofuranosyl)-1,9-dihydro- 6H-Purin-6-one,9-(3-deoxy-3-fluoro-beta-D-xylofuranosyl)-1,9-dihydro- | [Molecular Formula]
C10H11FN4O4 | [MDL Number]
MFCD31707544 | [MOL File]
171667-46-2.mol | [Molecular Weight]
270.22 |
Hazard Information | Back Directory | [Uses]
3’-Deoxy-3’-fluoro-beta-D-xylo-inosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | [References]
[1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
|
Company Name: |
NewCan Biotech Limited
|
Tel: |
+86-0571-86912261 +86-15658003402 |
Website: |
https://www.newcanbio.com/ |
|